申请人:E. R. Squibb & Sons, Inc.
公开号:US05202330A1
公开(公告)日:1993-04-13
Pyrimidine compounds of the formula ##STR1## wherein X is sulfur or oxygen, Y is R.sub.11 or --O--R.sub.1, and R.sub.4 is aryl or heterocyclo are disclosed. These compounds are useful as cardiovascular agents, particularly anti-hypertensive agents, due to their calcium entry blocking vasodilator activity.
公开了符合以下公式的嘧啶化合物##STR1##其中X是硫或氧,Y是R.sub.11或--O--R.sub.1,R.sub.4是芳香族或杂环。这些化合物由于其钙通道阻滞血管扩张剂活性而被用作心血管药物,特别是抗高血压药物。